Back
Alector Vs. AbbVie Industry Stock Comparison
Sell
20
ALEC
Alector
Last Price:
$1.86
Seasonality Move:
-4.84%
Sell
40
ABBV
AbbVie
Last Price:
$175.68
Seasonality Move:
1.78%
Sell
40
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
-
ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALEC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.61 | Sell |
Relative Strength Index (14 RSI): | 25.92 | Sell |
Chaikin Money Flow: | 3066328 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.86 - 3.44) | Sell |
Bollinger Bands (100): | (3.31 - 5.71) | Sell |
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.42 | Sell |
Relative Strength Index (14 RSI): | 46.96 | Sell |
Chaikin Money Flow: | 10543412 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (169.89 - 179.79) | Buy |
Bollinger Bands (100): | (178.35 - 198.21) | Sell |
ALEC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.93 | Sell |
20-day SMA: | 2.36 | Sell |
50-day SMA: | 3.86 | Sell |
200-day SMA: | 4.95 | Sell |
8-day EMA: | 1.95 | Sell |
20-day EMA: | 2.46 | Sell |
50-day EMA: | 3.44 | Sell |
200-day EMA: | 4.83 | Sell |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 173.51 | Buy |
20-day SMA: | 176.68 | Sell |
50-day SMA: | 182.88 | Sell |
200-day SMA: | 178.79 | Sell |
8-day EMA: | 174.1 | Buy |
20-day EMA: | 175.92 | Sell |
50-day EMA: | 180.64 | Sell |
200-day EMA: | 178.22 | Sell |
Alector Earnings Growth & ALEC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.23 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.24 per share.
Alector Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
AbbVie Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |